name: Tau Venturesstage: pausedtemperature: warmcheck_size: ~$500Klast_contact: 2026-02-06next_step: Send deck; he'll think about intros
Tau Ventures
Overview
- Stage focus: Seed, healthcare side
- Check size: ~$500K (don't lead, second/third largest check)
- Healthcare thesis: Looking at non-sexy parts of healthcare (supply chain, financial operating systems). Interested in AI doctors, regulatory shifts. Portfolio includes Alafia (fraud/miscoding).
- Key people: Sam Bogrov (healthcare team)
Relationship History
| Date | Type | Notes |
|---|---|---|
| Fall 2025 | Initial conversation | Discussed FDE thesis and new business models |
| 2026-02-06 | Catch-up / feedback | Great positioning feedback (blurb triggers "wrapper" fear). Valuation intel. Not right stage for Tau but offered to help with intros. |
Status
- Current stage: Friendly advisor / not investing this round
- Next step: Send deck. He'll think about intros. May revisit at next stage.
- Temperature: Warm (personal) but not a fit for this round
What They Care About
- Revenue before investing ("IRR coming through the door" — Tau-specific policy)
- Need a lead investor in place
- Domain expertise + deployment model (gets FDE thesis)
Concerns to Address
- Written positioning triggers "wrapper" fear — fix the blurb
- No revenue yet — Tau-specific gate
Materials Sent
- Deck (committed to sending)
Notes
- Most valuable as positioning feedback source and connector, not as investor for this round.
- Partners raising next fund — limited bandwidth across firm.
- Suggested connecting with: Zen/Emily, Tara (Flair), Hippo
- Revenue model breakdown in this call was the clearest yet — SaaS fee (5-10%) + implementation + maintenance/licensing (~50-60%). Worth refining.
- Cigna contact intel: payer tech systems are trash, everything manual, pilots die from integration complexity.